Healthcare - Biotechnology - NASDAQ - GB
$ 1.065
0.472 %
$ 37.4 M
Market Cap
-1.87
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
41.42%
Net Income
Estimate
--2146.78%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
OKYO Pharma Limited
OKYO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart OKYO
EBIT FORECAST
EBIT Forecast Chart OKYO
NET INCOME FORECAST
Net Income Chart OKYO